A gallery of up-to-date and stylish LaTeX templates, examples to help you learn LaTeX, and papers and presentations published by our community. Search or browse below.
This template gives a basic introduction to \(\mathrm{\LaTeX}\) and provides a template for the Creighton University Master's thesis, especially as pertains to the MS in physics and medical physics degrees.
This utmthesis class was first created back in 2006.
Since then, thanks to the various contributors over the years, it has matured into this.
List of major contributors (sorted alphabetically)
Lim Lian Tze
Loo Hui Ru
Muhammad Nadzir Marsono
Ng Choon Ching
Teo Hui Ming
Vishnu P. Nambiar
Yap Yung Szen
Wan Zuki Azman
credits also to other contributors/testers whose names are not listed here
UTMthesis.cls v6.4 (2021/05/02) conforms with the 2018 UTM thesis manual.
Chronic Myeloid Leukemia is a type of cancer that starts in certain blood-forming cells of the bone marrow. Interferon-\(\alpha\) was once the standard front-line treatment producing remission rates of only 28.3 percent in 1991. After the highly effective drugs first became available in 2001, survival rates have increased immensely. According to the American Cancer Society, one large study of CML patients treated with a drug called imatinib found that about 90 percent of them were still alive 5 years after starting treatment. While imatinib has changed the way oncologists treat CML, remission is common after extended gaps in treatment. In this paper, we will explore the long-term dynamics of CML under treatment through the use of use of theoretical and mathematical components. We closely base our methods upon the approach of Urszula Ledzewicz and Helen Moore. We will introduce our unique model and explain component selections, while we move towards understanding the optimal interactions of imatinib and interferon-\(\alpha\) against dormant and proliferating CML cells. Our future work involving optimal control dynamics will be briefly introduced and further solutions are currently ongoing.
Arianna Kalkandis
We only use cookies for essential purposes and to improve your experience on our site. You can find out more in our cookie policy.